Cancer statistics, 2016
TLDR
Overall cancer incidence trends are stable in women, but declining by 3.1% per year in men, much of which is because of recent rapid declines in prostate cancer diagnoses, and brain cancer has surpassed leukemia as the leading cause of cancer death among children and adolescents.Abstract:
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.read more
Citations
More filters
Journal ArticleDOI
Cancer statistics, 2019.
TL;DR: The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak.
Journal ArticleDOI
Cancer statistics, 2020.
TL;DR: Slow momentum for some cancers amenable to early detection is juxtaposed with notable gains for other common cancers, and it is notable that long‐term rapid increases in liver cancer mortality have attenuated in women and stabilized in men.
Journal ArticleDOI
Cancer statistics, 2017
TL;DR: The American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.
Journal ArticleDOI
Cancer Statistics, 2021.
TL;DR: In the United States, the cancer death rate has dropped continuously from its peak in 1991 through 2018, for a total decline of 31%, because of reductions in smoking and improvements in early detection and treatment as mentioned in this paper.
Journal ArticleDOI
Cancer treatment and survivorship statistics, 2016.
Kimberly D. Miller,Rebecca L. Siegel,Chun Chieh Lin,Angela B. Mariotto,Joan L. Kramer,Julia H. Rowland,Kevin Stein,Rick Alteri,Ahmedin Jemal +8 more
TL;DR: The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population and for the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors.
References
More filters
Posted Content
Long-Term Trends
TL;DR: A state rarity rank of S2S3 means: Imperiled or Vulnerable in New York Very vulnerable to disappearing from New York, or vulnerable to becoming imperiled, due to rarity or other factors; typically 6 to 80 populations or locations in Manhattan, few individuals, restricted range, few remaining acres (or miles of stream), and/or recent and widespread declines.
Journal ArticleDOI
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
C. Martin Tammemagi,David R. Nerenz,Christine Neslund-Dudas,Carolyn S. Feldkamp,David Nathanson +4 more
TL;DR: Effective control of comorbidity in black breast cancer patients should help improve life expectancy and lead to a reduction in survival disparities.
Journal ArticleDOI
Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults
William F. Anderson,M. Constanza Camargo,Joseph F. Fraumeni,Pelayo Correa,Philip S. Rosenberg,Charles S. Rabkin +5 more
TL;DR: Overall and age-specific incidence rates for noncardia gastric cancer declined among all race and age groups except for whites aged 25 to 39 years, for whom it increased, and a significant increase in whites among younger cohorts born since 1952.
Journal ArticleDOI
Quantifying the role of PSA screening in the US prostate cancer mortality decline
Ruth Etzioni,Alexander Tsodikov,Alexander Tsodikov,Angela B. Mariotto,Aniko Szabo,Aniko Szabo,Seth Falcon,Jake Wegelin,Jake Wegelin,Dante diTommaso,Dante diTommaso,Kent Karnofski,Roman Gulati,David F. Penson,Eric J. Feuer +14 more
TL;DR: PSA screening may account for much, but not all, of the observed drop in prostate cancer mortality, and other factors, such as changing treatment practices, may also have played a role in improving prostate cancer outcomes.
Deaths: Final Data for 2017.
TL;DR: In 2017, a total of 2,813,503 deaths were reported in the United States and the age-adjusted death rate was 731.9 deaths per 100,000 U.S. standard population, an increase of 0.4% from the 2016 rate as discussed by the authors.